RNAi农药市场－全球产业规模、份额、趋势、机会与预测：按应用、作物类型、产品、地区和竞争格局划分，2021-2031年

全球 RNAi 杀虫剂市场预计将从 2025 年的 17.2 亿美元成长到 2031 年的 30.4 亿美元，复合年增长率为 9.96%。

这些杀虫剂利用双链RNA序列诱导目标害虫基因静默，从而抑制必需蛋白质的合成，最终杀死害虫，且不会伤害非目标生物。市场成长主要受全球对无残留农产品需求不断增长以及害虫对传统化学杀虫剂抗药性日益增强的驱动。此外，支持性法规结构加快了生物作物保护剂的核准，为产业发展奠定了坚实的基础，使其超越了短暂的流行趋势。

儘管该领域潜力巨大，但仍面临许多挑战，包括双链RNA的高昂生产成本及其在环境条件下的快速降解，这些都限制了其实际应用。然而，近期行业统计数据显示，商业性商业性日益增强。

市场驱动因素

害虫对传统化学农药的抗药性日益增强，是全球RNAi农药市场的主要驱动力。随着目标生物对现有合成化合物产生免疫力，农业部门正面临产量稳定性下降和病虫害控製成本飙升的双重困境，因此迫切需要新的作用机制，例如能够使特定基因惰性的RNA干扰。这种经济压力十分严峻，凸显了对有效生物替代疗法的迫切需求。根据《马铃薯商业》杂誌2024年1月报道，化学农药抗药性问题的蔓延预计每年将给美国农业部门造成至少100亿美元的损失，生产者正在寻求既能规避这些抗药性机制又能保护环境的解决方案。

同时，RNAi递送技术和製剂稳定性的技术突破正在有效克服与田间永续性和生产成本相关的传统挑战。近期创新使得将双链RNA封装在稳健的载体中成为可能，从而确保其在各种环境条件下均能有效发挥作用，并获得监管部门的核准。例如，根据GreenLight Biosciences公司2024年1月发布的公告，其新註册的生物农药Calantha的田间试验表明，仅需每英亩4克的低施用量即可有效控制害虫。这种精准度反映了该行业在开发高度稳定、可直接用于田间试验的产品方面取得的进展，并吸引了更多投资。作为这种投资动能的例证，AgroSpheres公司于2024年9月获得了3,700万美元的B轮资金筹措，以扩大其专有的生物製造和递送平台。

市场挑战

双链RNA（dsRNA）的高生产成本及其在环境中的快速降解，严重阻碍了全球RNAi农药市场的商业性化规模化。这些特殊RNA序列的生产需要复杂的发酵或化学合成工艺，其高成本远高于传统农药，使得最终产品在许多低利润主粮作物上难以应用。这种价格差距限制了该技术的竞争力，迫使生产者专注于高价值的细分市场，而非大规模农业生产。

此外，裸露的双股RNA本身稳定性较差，且易受紫外线和雨水侵蚀而迅速降解，因此开发先进的包封技术至关重要。这项要求进一步增加了技术复杂性和研发成本，延缓了产品上市。根据国际作物生命联盟（CropLife International）预测，到2024年，发现、开发和註册一种新的作物保护活性成分的平均成本将达到3.01亿美元，研发週期超过12年。如此庞大的资金和时间投入提高了进入门槛，阻碍了中小型生技公司的投资，并减缓了RNAi领域产品商业化的整体步伐。

市场趋势

喷洒型和施用型RNAi生物农药的商业化进程正迅速从田间试验阶段迈向市场渗透阶段，这主要得益于旨在扩大产能的大规模后期融资。随着技术的日益成熟，越来越多的公司正在筹集必要的资金，以扩大叶面喷布解决方案的产能，从而实现无残留病虫害防治。例如，GreenLight Biosciences于2025年3月完成了由Just Climate主导的2500万美元C资金筹措，用于支援其已註册的RNA农作物保护产品的商业化部署。这凸显了该产业正从研发阶段转向商业化执行阶段的转变。

同时，大型农药公司与生技新兴企业之间的策略合作正在重塑竞争格局。透过将新兴企业的基因静默技术与成熟企业的全球分销网络相结合，跨国公司可以迅速将尖端的基因编辑技术和RNAi特性整合到其产品组合中，而中小型创新企业则能够进入广阔的国际市场。例如，先正达蔬菜种子有限公司于2025年5月宣布将与Tropic公司合作，将其基因编辑诱导基因静默（GEiGS）技术推广到全球90多个国家。这正是利用成熟农药生产商庞大的商业性网络加速精准生物性状应用的一种共生经营模式的典范。

目录

第一章概述

第二章：调查方法

第3章执行摘要

第四章：客户心声

第五章：全球RNAi农药市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 透过应用（害虫防治、杂草防治、病害防治、抗药性管理）
  • 作物类型（农业用途、非农业用途）
  • 产品分类（热带RNAi杀虫剂、种子嵌入式RNAi、基因改造RNAi、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美RNAi农药市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲RNAi农药市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区RNAi农药市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲RNAi农药市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美RNAi农药市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球RNAi农药市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Bayer CropScience
• Syngenta
• Corteva Agriscience
• Evogene
• RNAissance
• Benson Hill
• Vestaron
• AgBiome
• DSV Biotech
• NRC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global RNAi Pesticides Market is projected to expand from USD 1.72 Billion in 2025 to USD 3.04 Billion by 2031, registering a compound annual growth rate of 9.96%. These pesticides function by utilizing double-stranded RNA sequences to induce gene silencing in targeted pests, thereby inhibiting essential protein synthesis and causing mortality without harming non-target organisms. The market is largely propelled by the critical global requirement for agricultural produce free of residues and the mounting resistance of pests to traditional chemical synthetics. Additionally, supportive regulatory frameworks that expedite the approval of biological crop protection agents provide a solid foundation for industry expansion, distinguishing it from temporary adoption trends.

Despite this potential, the sector encounters a significant hurdle regarding the high expense of double-stranded RNA production and its rapid degradation in environmental conditions, which complicates field application. However, commercial confidence in the broader sector remains robust, as reflected in recent industry statistics. Data from the International Biocontrol Manufacturers Association indicates that in 2024, the European biocontrol market reached a value of 1.6 billion euros following a doubling of the sector size since 2016. This substantial growth in the parent industry highlights the increasing commercial feasibility of biological alternatives such as RNAi.

Market Driver

The escalating resistance of pests to conventional chemical pesticides serves as the primary catalyst driving the Global RNAi Pesticides Market. As target organisms develop immunity to existing synthetic compounds, the agricultural sector confronts diminishing yield security and spiraling control costs, creating an urgent imperative for novel modes of action like RNA interference that can silence specific genes. This economic pressure is severe and underscores the financial necessity for effective biological alternatives; according to Potato Business in January 2024, the growing issue of chemical pesticide resistance is predicted to cost the United States agricultural sector at least USD 10 billion annually, prompting growers to seek solutions that bypass these resistance mechanisms while preserving environmental integrity.

Simultaneously, technological breakthroughs in RNAi delivery and formulation stability are effectively dismantling historical barriers related to field persistence and production costs. Recent innovations have enabled the encapsulation of double-stranded RNA in robust carriers, ensuring efficacy in diverse environmental conditions and securing regulatory validation. For instance, according to GreenLight Biosciences in January 2024, field trials for its newly registered Calantha bioinsecticide demonstrated effective pest control with application rates as low as 4 grams per acre. Such precision demonstrates the sector's progress in creating stable, field-ready products, which is further attracting significant capital; illustrating this investment momentum, AgroSpheres secured $37 million in Series B funding in September 2024 to scale its proprietary biomanufacturing and delivery platform.

Market Challenge

The high cost of double-stranded RNA (dsRNA) production combined with its rapid environmental degradation constitutes a severe impediment to the commercial scalability of the Global RNAi Pesticides Market. Manufacturing these specialized RNA sequences involves complex fermentation or chemical synthesis processes that remain significantly more expensive than conventional agrochemicals, making the final product economically unfeasible for many low-margin staple crops. This price disparity limits the technology's competitiveness, forcing manufacturers to restrict their focus to high-value niche markets rather than broad-acre agriculture.

Furthermore, the inherent instability of naked dsRNA, which breaks down quickly under UV light and rain, necessitates the development of sophisticated encapsulation technologies. This requirement adds layers of technical complexity and developmental expense, further delaying market entry. According to CropLife International, in 2024, the average cost to discover, develop, and register a new crop protection active ingredient reached $301 million, with a development timeline extending over 12 years. These immense capital and time requirements create high barriers to entry, discouraging investment from smaller biotech firms and slowing the overall rate of product commercialization within the RNAi sector.

Market Trends

The commercialization of sprayable and topical RNAi biopesticides is rapidly transitioning from experimental field trials to active market penetration, supported by substantial late-stage capital injections aimed at scaling manufacturing capabilities. As the technology matures, companies are securing the necessary financial resources to expand production capacities for foliar-applied solutions that offer residue-free pest control. Illustrating this push toward mass-market availability, according to GreenLight Biosciences in March 2025, the company closed a $25 million Series C funding round led by Just Climate to support the commercial rollout of its registered RNA-based crop protection products, highlighting the industry's shift from discovery to commercial execution.

Strategic collaborations between agrochemical giants and biotech startups are simultaneously reshaping the competitive landscape by combining the specialized gene-silencing platforms of emerging firms with the global distribution networks of established incumbents. These partnerships allow large multinationals to rapidly integrate cutting-edge gene-editing and RNAi traits into their portfolios while providing smaller innovators access to vast international markets. For instance, according to Syngenta Vegetable Seeds in May 2025, the company entered a collaboration with Tropic to deploy the Gene Editing induced Gene Silencing (GEiGS) technology across its global footprint, which spans more than 90 countries, underscoring a symbiotic business model where the immense commercial reach of legacy agrochemical players is leveraged to accelerate the deployment of precise biological traits.

Key Market Players

• Bayer CropScience
• Syngenta
• Corteva Agriscience
• Evogene
• RNAissance
• Benson Hill
• Vestaron
• AgBiome
• DSV Biotech
• NRC

Report Scope

In this report, the Global RNAi Pesticides Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

RNAi Pesticides Market, By Application

• Insect Pest Control
• Weed Management
• Disease Management
• Resistance Management

RNAi Pesticides Market, By Crop Type

• Agricultural Application
• Non-Agricultural Application

RNAi Pesticides Market, By Product

• Tropical RNAi Pesticide
• Seed Embedded RANi
• Transgenic RNAi
• Others

RNAi Pesticides Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global RNAi Pesticides Market.

Available Customizations:

Global RNAi Pesticides Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global RNAi Pesticides Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management)
  • 5.2.2. By Crop Type (Agricultural Application, Non-Agricultural Application)
  • 5.2.3. By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America RNAi Pesticides Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Crop Type
  • 6.2.3. By Product
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States RNAi Pesticides Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Crop Type
      • 6.3.1.2.3. By Product
  • 6.3.2. Canada RNAi Pesticides Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Crop Type
      • 6.3.2.2.3. By Product
  • 6.3.3. Mexico RNAi Pesticides Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Crop Type
      • 6.3.3.2.3. By Product

7. Europe RNAi Pesticides Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Crop Type
  • 7.2.3. By Product
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany RNAi Pesticides Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Crop Type
      • 7.3.1.2.3. By Product
  • 7.3.2. France RNAi Pesticides Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Crop Type
      • 7.3.2.2.3. By Product
  • 7.3.3. United Kingdom RNAi Pesticides Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Crop Type
      • 7.3.3.2.3. By Product
  • 7.3.4. Italy RNAi Pesticides Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Crop Type
      • 7.3.4.2.3. By Product
  • 7.3.5. Spain RNAi Pesticides Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Crop Type
      • 7.3.5.2.3. By Product

8. Asia Pacific RNAi Pesticides Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Crop Type
  • 8.2.3. By Product
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China RNAi Pesticides Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Crop Type
      • 8.3.1.2.3. By Product
  • 8.3.2. India RNAi Pesticides Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Crop Type
      • 8.3.2.2.3. By Product
  • 8.3.3. Japan RNAi Pesticides Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Crop Type
      • 8.3.3.2.3. By Product
  • 8.3.4. South Korea RNAi Pesticides Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Crop Type
      • 8.3.4.2.3. By Product
  • 8.3.5. Australia RNAi Pesticides Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Crop Type
      • 8.3.5.2.3. By Product

9. Middle East & Africa RNAi Pesticides Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Crop Type
  • 9.2.3. By Product
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia RNAi Pesticides Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Crop Type
      • 9.3.1.2.3. By Product
  • 9.3.2. UAE RNAi Pesticides Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Crop Type
      • 9.3.2.2.3. By Product
  • 9.3.3. South Africa RNAi Pesticides Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Crop Type
      • 9.3.3.2.3. By Product

10. South America RNAi Pesticides Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Crop Type
  • 10.2.3. By Product
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil RNAi Pesticides Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Crop Type
      • 10.3.1.2.3. By Product
  • 10.3.2. Colombia RNAi Pesticides Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Crop Type
      • 10.3.2.2.3. By Product
  • 10.3.3. Argentina RNAi Pesticides Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Crop Type
      • 10.3.3.2.3. By Product

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global RNAi Pesticides Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bayer CropScience
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Syngenta
• 15.3. Corteva Agriscience
• 15.4. Evogene
• 15.5. RNAissance
• 15.6. Benson Hill
• 15.7. Vestaron
• 15.8. AgBiome
• 15.9. DSV Biotech
• 15.10. NRC

16. Strategic Recommendations

17. About Us & Disclaimer